Elevai Labs, Inc. (ELAB)
NASDAQ: ELAB · IEX Real-Time Price · USD
0.683
-0.006 (-0.89%)
At close: May 9, 2024, 4:00 PM
0.689
+0.006 (0.83%)
After-hours: May 9, 2024, 7:43 PM EDT
Elevai Labs Revenue
In the year 2023, Elevai Labs had annual revenue of $1.71M with 123.50% growth. Revenue in the quarter ending December 31, 2023 was $698.59K with 61.67% year-over-year growth.
Revenue (ttm)
$1.71M
Revenue Growth
+123.50%
P/S Ratio
6.91
Revenue / Employee
$95,144
Employees
18
Market Cap
11.83M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.71M | 946.32K | 123.50% |
Dec 31, 2022 | 766.28K | 765.45K | 92,557.44% |
Dec 31, 2021 | 827.00 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionELAB News
- 7 days ago - Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity - GlobeNewsWire
- 8 days ago - Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare - GlobeNewsWire
- 8 days ago - Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments - GlobeNewsWire
- 10 days ago - Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments - GlobeNewsWire
- 17 days ago - ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months - GlobeNewsWire
- 5 weeks ago - Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results - GlobeNewsWire
- 7 weeks ago - Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market - GlobeNewsWire
- 3 months ago - ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office - GlobeNewsWire